Opus Genetics gets FDA Fast Track designation for Phentolamine Ophthalmic Solution
Opus Genetics (IRD) said that the FDA has granted Fast Track designation for Phentolamine Ophthalmic Solution 0.75% as a ...
Opus Genetics Announces FDA Fast Track and Enrollment Updates for Phentolamine Ophthalmic Solution 0.75% Programs
FDA Fast Track Designation granted for Phentolamine Ophthalmic Solution 0.75% as treatment of significant chronic night ...
Hosted on MSN4d
Pinellas mother of boy with rare metabolic disorder pushes for more accessible medical food
A Pinellas County mom is pushing for more accessible medical food for her 4-year-old son diagnosed with a rare metabolic disorder.
Opus Genetics gets Fast Track designation for phentolamine ophthalmic solution
Opus Genetics (IRD) announced completion of enrollment in the VEGA-3 Phase 3 clinical trial evaluating Phentolamine Ophthalmic Solution 0.75% ...